CHRISTINA NELSON ARNP
Prescription History 1750656542
Nurse Practitioner - Family in Davenport, IA
NPI Status: Active since March 13, 2012
Contact Information
1236 E RUSHOLME ST STE 300
DAVENPORT, IA
ZIP 52803
Phone: (563) 324-2992
Fax: (563) 324-8562
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions CHRISTINA NELSON ARNP has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Albuterol Sulfate
- Specialty
- Nurse Practitioner
- Times Prescribed
- 15
- Number of 30-Day Refills Prescribed
- 15
- What is this prescription?
- A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
- What is this prescription used for?
- Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school.
- Generic Name
- Nirmatrelvir/Ritonavir
- Specialty
- Nurse Practitioner
- Times Prescribed
- 20
- Number of 30-Day Refills Prescribed
- 20
- What is this prescription used for?
- The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.